期刊文献+

口服免疫机制及口服疫苗的研究进展 被引量:7

Oral Immunity and Oral Vaccine: Mechanism, Progress and Prospects
原文传递
导出
摘要 口服免疫可诱导机体产生有效的免疫应答和免疫耐受。其通过胃肠粘膜进行抗原递呈 ,较经传统注射途径的免疫效果和依从性好 ,且简易便捷 ,是更为理想的免疫途径。口服疫苗有多种载体系统 ,某些经改造的细菌如沙门氏菌、大肠杆菌、特别是乳酸菌属被认为是有前景的口服疫苗载体 ,因口服后可在肠道寄生繁殖 ,故可大大提高免疫的效率。本文围绕口服免疫主要的机制和口服疫苗的研究进展进行综述。 Oral immunity is known to be appropriate for immune activation as well as tolerance induction, in which antigen presenting is completed through a mucosal route. It has been demonstrated to be an optimal way for immunity, better than through a traditional way of injection in immunoregulation efficacy, compliance and administration approach. There are many vector systems of bacteria serving as carriers for oral vaccines, including some attenuated Salmonella, Escherichia coli, particularly lactic acid bacteria, as a safe organism, which has been considered to be a perspective candidate carriers for oral vaccine because of its lower intrinsic immunogenicity.
作者 李理 徐军
出处 《医学分子生物学杂志》 CAS CSCD 2004年第5期316-319,共4页 Journal of Medical Molecular Biology
  • 相关文献

参考文献23

  • 1Maassen CB, Laman JD, den Bak-Glashouwer MJ, et al.Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclero
  • 2Shaw KM, Gaerthe B, Leer RJ, et al. Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C-expressing lactobacilli. Immunol
  • 3Porter DC, Ansardi DC, Morrow CD. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. J Virol, 1995, 69:1 548-55.
  • 4MacDonald TT, Monteleone G. IL-12 and Th1 immune responses in human Peyer's patches. Trends Immunol, 2001,22 : 244-7.
  • 5Ryan EJ, Daly LM, Mills KH, et al. Immunomodulators and delivery systems for vaccination by mucosal routes.Trends Biotechnol, 2001, 19: 293-304.
  • 6Russo M, Nahori MA, Lefort J, et al. Suppression of asthma-like responses in different mouse strains by oral tolerance. Am J Respir Cell Mol Biol, 2001, 24: 518-26.
  • 7Fujihashi K, Dohi T, Rennert PD, et al. Peyer's patches are required for oral tolerance to proteins. Proc Natl Acad Sci USA, 2001, 98:3 310-5.
  • 8Maeda Y, Noda S, Tanaka K, et al. The failure of oral tolerance induction is functionally coupled to the absence of T cells in Peyer's patches under germfree conditions. Immunobiology, 2001, 204: 442-57.
  • 9Flo J, Tisminetzky S, Baralle F, et al. Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice. Vaccine, 2001, 19:1 772-82.
  • 10Kawamura YI, Kawashima R, Shirai Y, et al. Cholera toxin activates dendritic cells through dependence on GM1ganglioside which is mediated by NF-kappaB translocation Eur J Immunol, 2003, 33: 3 205-12.

同被引文献61

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部